Skip to main content
. Author manuscript; available in PMC: 2023 Aug 24.
Published in final edited form as: Expert Opin Drug Metab Toxicol. 2022 Aug 24;18(7-8):469–481. doi: 10.1080/17425255.2022.2113379

Figure 6. Concentration of drug in plasma during maintenance therapy under condition in which a patient’s toxicity threshold is low relative to the majority of patients.

Figure 6.

As mentioned in the text, a variety of factors can lead to a reduced toxicity threshold for an individual. Without prior knowledge of this, normal maintenance therapy could lead to concentrations of drug in plasma that exceed the lower-than-normal toxicity threshold (compare to Fig. 2).